Last week, in a pre-Halloween treat mode, CMS released a revised Workers’ Compensation Medicare Set-Aside (WCMSA) Reference Guide. The updated guide is version 3.0, dated October 10, 2019, and can be found here. As with other versions of the guide, updates are found in Section 1.1. Of the updates, there are two of great significance […] Continue
The Centers for Medicare & Medicaid Services (CMS) issued a revised Self-Administration Toolkit for Workers’ Compensation Medicare Set-Aside (WCMSA) Arrangements, version 1.3 yesterday. The purpose of this toolkit is to describe the WCMSA self-administration process and provide guidelines for claimants who are administering their own WCMSA. Specifically, the toolkit: Describes the self-administration process, from when […] Continue
One component of the FDA’s drug approval process is a designation of the drug as prescription only or over-the-counter (OTC). If a drug is initially approved as a prescription only medication, this doesn’t mean that the drug cannot later be approved for over-the-counter status. In order to facilitate this change, the drug manufacturer files a […] Continue
Starting October 12, the Centers for Medicare and Medicaid Services (CMS) will begin using the CDC’s “Table 1: Life Table for the total population: United States, 2016” for Workers’ Compensation Medicare Set Aside (WCMSA) life expectancy calculations. This means that for any WCMSA proposal received by CMS through the voluntary review program, or where any […] Continue
You may recall that in 2018 we reported that a Senate Bill was introduced, “[t]o amend title XVIII of the Social Security Act to provide for the application of Medicare secondary payer rules to certain workers’ compensation settlement agreements and qualified Medicare set-aside provisions.” As we described it, the Bill was a piece of legislation to […] Continue